Clinical Trials
2 trialsNCT01190930 2026-05-28
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Children's Oncology Group
Phase 3 Completed
NCT01116193 2017-09-14
RV-405 LAL
Institut de Cancérologie de la Loire
Phase 2 Completed